BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 19, 2010
View Archived Issues
Clinical development of ChimeriVax-Dengue vaccine updated
Read More
EVX-001650 displays antipsychotic activity in mouse models related to schizophrenia
Read More
AC-430 confers protection in models of autoimmune and inflammatory conditions
Read More
Proof-of-concept secukinumab trial in ankylosing spondylitis meets primary endpoint
Read More
Exelixis divulges novel mTORC1 inhibitors
Read More
Aveo Pharma advances phase Ib tivozanib/capecitabine combination trial
Read More
Orban Biotech receives Qualifying Therapeutic Discovery grant for IBC-VS01 vaccine
Read More
Salvat licenses tarafenacin to Kwang Dong Pharma for OAB in South Korea
Read More
Morphotek and Hokkaido University join to evaluate amatuximab for pancreatic cancer
Read More
Decreased IGF-I levels may correlate with growth defects in newborns with cystic fibrosis
Read More
Bristol-Myers Squibb updates pipeline progress for Q3 of 2010
Read More
Ipsen Pharma identifies new imidazolidine-2,4-dione derivatives for prostate cancer
Read More
Banyu Pharma presents new peptide P518 receptor antagonists
Read More
Lumixex launches diagnostic xTAG CYP2D6 Kit in U.S.
Read More
Circassia's Toleromune House Dust Mite vaccine shows promise in phase II trial
Read More
Genzyme to sell diagnostics business to Sekisui Chemical
Read More
Astex Therapeutics claims new fibroblast growth factor receptor inhibitors
Read More
Errant Gene Therapeutics receives U.S. federal grant for Thalagen research
Read More
Advanced Life Sciences applies for FDA orphan drug status for ALS-886 in ARDS
Read More
Phytopharm advances phase II smilagenin trial in early-stage Parkinson's disease
Read More
New GlyT-1 inhibitors claimed by sanofi-aventis
Read More
Phase III APPRAISE-2 trial of apixaban in ACS discontinued
Read More
Reolysin to enter phase I trial in pediatric patients with solid tumors
Read More
FDA approves Xgeva for SRE prophylaxis in patients with bone metastases from solid tumors
Read More
Second interim RESTORE-CLI data analysis shows primary endpoints met
Read More